////// Science for a better life
Pharmaceuticals focuses on prescription drugs for the therapeutic areas of cardiology, oncology, gynecology, hematology & ophthalmology.
Consumer Health brings consumers some of the world’s best-known and most trusted over-the-counter (OTC) medications, nutritional supplements and other self-care products.
Crop Science has businesses in seeds, crop protection and non-agricultural pest control.
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives.
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
Investing in a stronger future - for our shareholders, and for the world.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
Whether you weren’t able to attend or want to review the meeting’s minutes, we’ve compiled a variety of resources to help summarize notable updates and discussions during our most recent Annual Stockholders’ Meeting.
Webcast with presentation slides
Opening of the Annual Stockholders’ Meeting:
Werner Wenning (16:20 min., 7.50 MB)
Report of the Board of Management:
Werner Baumann (37:52 min., 17.3 MB)
Report of the Supervisory Board:
Werner Wenning (21:59 min., 10.0 MB)
Introduction as future Chairman of the Supervisory Board:
Prof. Dr. Norbert Winkeljohann (03:58 min., 1.85 MB)
Farewell as Chairman of the Supervisory Board:
Werner Wenning (04:27 min., 2.07 MB)
Remarks on the change in chairmanship of the Supervisory Board:
Oliver Zühlke (03:53 min., 1.80 MB)
Replies to stockholders' questions:
Werner Baumann, Wolfgang Nickl, Werner Wenning, Prof. Dr. Norbert Winkeljohann (238:32 min., 95.50 MB)
Werner Wenning (09:28 min., 8.69 MB)
Werner Wenning (13:49 min., 12.6 MB)
Address by Werner Baumann
View the outcome of votes during the 2020 Annual Stockholder Meeting, attended by 64.02% of the statutory capital of Bayer AG. This report includes the votes cast by postal voting.